University of Houston: A New Weapon Against the Super Tough C Diff Bacteria
December 20, 2023
December 20, 2023
HOUSTON, Texas, Dec. 20 (TNSres) -- The University of Houston issued the following news release:
* * *
Phase 1 Trial Shows New RX Fights C Diff and Spares Healthy Microbiota
* * *
In a phase-one human clinical trial, a University of Houston pharmacist researcher has demonstrated that a newer generation tetracycline antibiotic, called Omadacycline, may be a promising tool in combating the resilient bacteria Clostridioides difficile (C diff), whi . . .
* * *
Phase 1 Trial Shows New RX Fights C Diff and Spares Healthy Microbiota
* * *
In a phase-one human clinical trial, a University of Houston pharmacist researcher has demonstrated that a newer generation tetracycline antibiotic, called Omadacycline, may be a promising tool in combating the resilient bacteria Clostridioides difficile (C diff), whi . . .